AOD9604 5 mg

Ingredient:C-terminal fragment of the Human growth hormone

Pack : 5 mg x 1 vial

What is AOD9604?
AOD9604 (also known as "Advanced Obesity Drug") is a synthetic peptide fragment comprising the last 17 amino acids (176-191) of the human growth hormone (hGH) molecule. This fragment was specifically designed to retain the fat-metabolizing properties of hGH without its growth-promoting or insulin-antagonistic effects. This 5 mg product is supplied as a highly pure, lyophilized powder for controlled laboratory research.

What does it do?
AOD9604 works primarily by mimicking the way natural growth hormone stimulates fat breakdown (lipolysis) and inhibits fat storage (lipogenesis). It targets fat cells (adipocytes) directly, promoting the release of stored triglycerides and enhancing the body's ability to utilize fat as an energy source. Unlike full-length GH, it does not significantly bind to GH receptors responsible for growth.

How is it used?
This compound is provided exclusively for in-vitro (laboratory) research applications. It is not for human or animal consumption. For experimental use, it must be reconstituted with an appropriate sterile solvent, such as bacteriostatic water or phosphate-buffered saline (PBS). All subsequent handling, dosing, and application in cell cultures or biochemical assays must be performed according to specific, pre-defined research protocols in a qualified laboratory setting, adhering to all biosafety standards.

Potential Benefits (in a research context):

• Targeted Fat Metabolism Research: Serves as a precise tool for studying the mechanisms of lipolysis and lipogenesis in adipocyte cell lines.

• Obesity & Metabolic Syndrome Studies: Highly relevant for research on obesity, metabolic disorders, and non-alcoholic fatty liver disease (NAFLD) pathways.

• Improved Metabolic Parameters: Useful in studies investigating improvements in lipid profiles, insulin sensitivity, and glucose metabolism without the diabetogenic risk of full GH.

• Cartilage & Joint Health Studies: Shows potential in models of cartilage repair and chondrocyte proliferation, relevant to osteoarthritis research.

• Wound Healing Models: May support research on tissue regeneration and wound repair due to its metabolic effects.

Possible Side Effects (research observations):
Based on scientific literature and clinical trial data, AOD9604 is generally noted for its favorable safety profile with minimal side effects. Observed or theoretical effects in research models include:

• Excellent Tolerability: Early human trials reported no significant systemic side effects, growth effects, or impact on glucose tolerance.

• Minimal Adverse Events: Occasional reports of mild, transient reactions such as headache or fatigue in clinical studies were comparable to placebo.

• Local Reactions: In subcutaneous administration models, potential for minor, temporary redness or discomfort at the injection site.

• Important Note: While preclinical and limited clinical data are promising, comprehensive long-term safety data from large-scale human studies is not yet available.